Critical

Carcinoid crisis

Vasoactive surge · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A surge of vasoactive substances from a carcinoid tumour causes flushing, bronchospasm and unstable blood pressure, often triggered by procedures. Octreotide is the treatment.

Assessment

Investigations

  • Recognise the trigger/history
  • Monitoring
  • Bloods

Management

  • Octreotide to control the crisis
  • Supportive haemodynamic care
  • Avoid catecholamines where possible
  • Treat bronchospasm
  • Specialist involvement

Drugs & doses

Octreotide

Disposition

HDU/ICU; specialist.

Octreotide, not adrenaline, is the key treatment for carcinoid crisis hypotension.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.